Product Information

LAMOTRIGINE ER 300 MG TABLET is a generic product labeled by NorthStar Rx LLC, priced at $1.2133 per EA under NDC 16714062701. Its NADAC has been published 459 times since Nov 8, 2017.

FDA first approved this application on Jun 19, 2013. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

LAMOTRIGINE ER 300 MG TABLET

Lamotrigine
$1.2133per EA

Strength

300 mg/1

Manufacturer

NorthStar Rx LLC

NDC

16714062701

Classification

Generic

Dosage Form

TABLET, EXTENDED RELEASE

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

LAMOTRIGINE

Approval Type

Generic (ANDA)

FDA Application

ANDA202383

FDA Approved

6/19/2013

TE Code

AB

On Market Since

6/20/2017

Pharmacological Classes

Anti-epileptic Agent
Decreased Central Nervous System Disorganized Electrical Activity
Dihydrofolate Reductase Inhibitors
Mood Stabilizer
Organic Cation Transporter 2 Inhibitors

Price Statistics

The NADAC for LAMOTRIGINE ER 300 MG TABLET has been published 459 times since Nov 8, 2017, and over the history we have for it it has declined 86.2%. The table below summarizes its recorded NADAC range and movement.

Current price$1.2133 per EA
All-time high$8.7934 (Nov 15, 2017)
All-time low$0.9867 (Nov 20, 2024)
52-week high$1.4630
52-week low$1.1920
Median price$3.8031
Average price$3.6195
Largest weekly change+59.8% (Jun 19, 2024)
Weeks tracked459
Tracking sinceNov 8, 2017

Price History

1W

+1.8%

1M

+1.8%

3M

+1.0%

6M

-9.5%

1Y

-8.1%

3Y

-44.0%

5Y

-66.3%

All

-86.2%

Generic Alternatives

The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of LAMOTRIGINE ER 300 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for LAMOTRIGINE ER 300 MG TABLET, manufactured by NorthStar Rx LLC, is $1.2133 per EA (NDC 16714062701), effective Aug 19, 2026.

How has the price of LAMOTRIGINE ER 300 MG TABLET changed over time?

Over the history we have for it, the NADAC for LAMOTRIGINE ER 300 MG TABLET has declined 86.2%. It has been tracked across 459 weekly CMS publications since Nov 8, 2017.

What are the highest and lowest recorded NADAC prices for LAMOTRIGINE ER 300 MG TABLET?

Since Nov 8, 2017, the NADAC for LAMOTRIGINE ER 300 MG TABLET has ranged from a low of $0.9867 (Nov 20, 2024) to a high of $8.7934 (Nov 15, 2017), with a median of $3.8031 per EA.

Are there cheaper alternatives to LAMOTRIGINE ER 300 MG TABLET?

4 manufacturers publish a NADAC-priced product with the same active ingredient and strength as LAMOTRIGINE ER 300 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures LAMOTRIGINE ER 300 MG TABLET?

LAMOTRIGINE ER 300 MG TABLET (NDC 16714062701) is labeled by NorthStar Rx LLC, and CMS classifies it as a generic product.